These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2858193)

  • 1. Reversible ipecac myopathy.
    Mateer JE; Farrell BJ; Chou SS; Gutmann L
    Arch Neurol; 1985 Feb; 42(2):188-90. PubMed ID: 2858193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural pathology in emetine-induced myopathy.
    Halbig L; Gutmann L; Goebel HH; Brick JF; Schochet S
    Acta Neuropathol; 1988; 75(6):577-82. PubMed ID: 3376760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medically unexplained myopathy due to ipecac abuse.
    Rashid N
    Psychosomatics; 2006; 47(2):167-9. PubMed ID: 16508031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipecac-induced myopathy simulating dermatomyositis.
    Bennett HS; Spiro AJ; Pollack MA; Zucker P
    Neurology; 1982 Jan; 32(1):91-4. PubMed ID: 6119651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathy and ipecac abuse in a bulimic patient.
    Moldawsky RJ
    Psychosomatics; 1985 May; 26(5):448-9. PubMed ID: 2859632
    [No Abstract]   [Full Text] [Related]  

  • 6. Myopathy from surreptitious ipecac ingestion.
    Rosenberg NL; Ringel SP
    West J Med; 1986 Sep; 145(3):386-8. PubMed ID: 2876555
    [No Abstract]   [Full Text] [Related]  

  • 7. Ipecac myopathy and cardiomyopathy.
    Dresser LP; Massey EW; Johnson EE; Bossen E
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):560-2. PubMed ID: 8099367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders.
    Palmer EP; Guay AT
    N Engl J Med; 1985 Dec; 313(23):1457-9. PubMed ID: 2865679
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.
    Kuntzer T; Bogousslavsky J; Deruaz JP; Janzer R; Regli F
    J Neurol; 1989 May; 236(4):246-8. PubMed ID: 2760638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology of ipecac: a review.
    Manno BR; Manno JE
    Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emetine myopathy in a patient with an eating disorder.
    Thyagarajan D; Day BJ; Wodak J; Gilligan B; Dennett X
    Med J Aust; 1993 Dec 6-20; 159(11-12):757-60. PubMed ID: 8264462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?
    Silber TJ
    J Adolesc Health; 2005 Sep; 37(3):256-60. PubMed ID: 16109351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular diseases in relation to drug consumption].
    Uldry PA; Regli F
    Schweiz Rundsch Med Prax; 1989 Jun; 78(23):671-3. PubMed ID: 2568673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies.
    Hopf NJ; Goebel HH
    Acta Neuropathol; 1993; 85(4):414-8. PubMed ID: 8480514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death due to chronic syrup of ipecac use in a patient with bulimia.
    Schiff RJ; Wurzel CL; Brunson SC; Kasloff I; Nussbaum MP; Frank SD
    Pediatrics; 1986 Sep; 78(3):412-6. PubMed ID: 2875430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death from ipecac intoxication in a patient with anorexia nervosa.
    Friedman EJ
    Am J Psychiatry; 1984 May; 141(5):702-3. PubMed ID: 6143508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emetine myopathy: two case reports with pathobiochemical analysis.
    Sugie H; Russin R; Verity MA
    Muscle Nerve; 1984 Jan; 7(1):54-9. PubMed ID: 6700630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa.
    Brotman MC; Forbath N; Garfinkel PE; Humphrey JG
    Can Med Assoc J; 1981 Sep; 125(5):453-4. PubMed ID: 6116535
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion.
    Ho PC; Dweik R; Cohen MC
    Clin Cardiol; 1998 Oct; 21(10):780-3. PubMed ID: 9789704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.